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INTRODUCTION
Synergistic interactions between two different types of immunologically com-
petent lymphocytes, thymus-derived (T cells) and bone marrow-derived (B cells),
have been shown to occur in litmoral immune responses(I-4). Whether such
interactions take place in cell mediated immune responses is less clear. Recently,
a number of reports have described synergistic reactions between different
lymphoid cell populations in the production of graft versus host (GVH) dis-
ease(5-8) and in the production of delayed hypersensitivity lesions(9-11), two
forms of cellular immunity. In only one case, however, was there evidence that
both cell populations had immunologic specificity(6). In that case, neither of the
interacting cell populations were B cells.
It is well-known that in the reactions of delayed hypersensitivity, lymphocyte
(almost assuredly T cell): macrophage interactions take place in which the role
of the macrophage is nonspecific(12). That macrophages are derived from the
bone marrow lhas also been well demonstrated(12,13). Furthermore, in GVH
reactions it has been well demonstrated that foreign lymphocytes (in this case
it has been shown that these are T cells)(14-19) interact with host cells (some of
which have been shown to come from the bone marrow) in the production of the
splenomegaly which is associated with that disease. This has been interpreted to
mean that the B cell in this case fulfills a role similar to that seen in delayed
hypersensitivity lesions, in that it is nonspecific(8). However, it is alternatively
possible that the foreign T cell acts as an antigen recognition cell that activates
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B cells to perform autoimmune reactions. For example, it hlas been slhown that
tolerant animals lhave B cells wlhiclh are (uite capable of making antibodies
against the tolerated antigen if they are activated by nontolerant T cells(20-21).
The possibility that a similar situation coukl exist in GVH reactioils is strengtli-
ened by the observation thiat these reactions are muclh easier to produce in new-
born animals than in adults(22). Newborn aniimals are relatively immunologically
incompetent, an(l tlherefore it may be that their B cells lhave not yet acquired
tolerance, and tlhtus are more easily activated. Similarly, sublethal irradliation
wlhiclh enlhainces GVH splenomegaly in adult recipients(22,23) is well-known to
abrogate tolerance(24).
We report liereini oIn a number of different attempts to (lemonstrate atlitoini-
nitine activity on the part of the B cell, all of wlhiclh were negative. We lhave dlone
tlhis by making secondlary tr-ansfers of spleens in wllich T:B cell interaction took
place to see if this producedl increasedl immunocom)etence of the cells in the
spleeni undtlergoinig GVH reactions. In addition, we lhave immunize(d mice in tlle
presenice of TF cells an(d tlhen removed tleii- T cells by use of an anti-tlheta serum
to see if ainy imnmunologic competence was then present in the B cell poLulation.
Our results suggest that most, if not all, interactions between T andl B cells in
GVH splenomegaly are immunologically nonspecific, or not concerned witlh the
generation of cells witlh GVH activity.
MATERIALS AND METHODS
Mice. All mice were obtained from the Jackson Laboratories, Bar Harbor,
Maine. They were kept in our animal colony for at least 1 week after shipment.
Recipient mice were male C3D2Fl mice (C3H/HE x DBA/2). Parental (lonor
mice were male C3H mice. C3H(H2K) ancl DBA(H9D) mice differ at the H2
locus and catuse a reliable GVH reaction(7,22).
Cell suispcnsionis. Spleen, lymph node and tlhymnus cell suspenisioins were Imade
by ctutting the freshi organis into small pieces and gently squashing thlemibetween
stemile glass slides in ice-cold meclitum 1\199. The cells were waslhe(d twvice before
use aind wer-e couintecd in a hemocytometer uising Trypan blue (lye exclusion
methlod as a test of viability. All cell suspensions were introd-ucedI via tail vein
inijections. Cell dlosages varied from 5 x 0; to 8 X 107 cells per mouse delivered
in a-i conistaint 0.2 ml.
Irradiationi. All irradiation was performedl witlh a Siemains Stabillipan 250 kV
X-1ay maclhine at a (lose rate of 85 R p/min. All CDF1 recipients received 350 R.
Subletlhal irradiatioii lhas been slhowni to enhlance the expression of GVH (lisease
among adlult inice(22,23).
Preparationi of bonie mnarrowzt reconistitnted mice. Bone marrow cell suspensions
were madle iy washling ouit the femurs of 8-week-old C3H mice witlh ice-cold
medium 1\1199. C3H recipients were thymectomized at 7 weeks. One week later,
these same mice receivecd 850 R (central axis dose) whole body irradiation. WVitlh-
in a few houirs they were given 5 X 10' viable syngeneic bone marrow cells via
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tail vein injection. The spleens of these animals served as a source of B cells.
However, since cells otlher than B cells were present in the bone marrow trans-
ferred, we shall refer to the entire population as bone marrow-derived cells
(BNIDC).
Preparationz of aniti-theta serun. This anti-serum was raised by the technique
of Reif(25). Seven weekly injections of 1 X 107 C3H tlhymocytes were made into
AKR mice. One week later these mice were exsanguinated and their serum
separatedl from the blood. Antibodies were titrated for cytotoxicity using Trypan
blue dye exclusioni as a measure of cell viability. Ninety-eight percent kill was
obtained wlhen one part anti-serum (diluted 1:20) was mixed with one part C3H
thymocytes (1 X 107/cc) and one part guinea pig complement.
Skin graft chimeras. C3H adults were thymectomized, lethally irradiated 1 week
later and imme(liately reconstituted witlh 5 x 106 syngeneic bone marrow cells.
Fresh skin from adult DBA mice was cut into squares, 1.5 X 1.5 cm and grafted
to the left flank of C3H adult chiimeras after the method of Billinglham and
MIedawar(26). They were examiined daily for signs of rejection.
Assay of graft versuis hlost activity. Spleens were lharvested on day 14 as previous
studlies lha(l sliowIn this was the time of maximal splenomegaly(7). They were
weighedl as were the mice from whichl they came and the results are expressed
in terms of spleen/body weight ratio.
Statistical anialysis. All statistical analyses were performed using Student's t test.
RESULTS
The first experiment we report tests the requiremeint for foreignness of the two
cell populations (T cells andl B\IDC) in the synergistic proluction of GVH
splenomegaly. In this experiment 7-week-old CDF1 mice were given 350 R of
X-irradiationi and( then were inoculate(d with eitlher parental (C3H) or syngeneic
(CDF,) tlhymocytes; parlental or syngenieic B_MDC; or a combination of thymo-
cytes an(d BNIDC ill a 1:1 ratio. All mice received the same total of cells (3 X 104).
The results (Table 1) show that significant splenomegaly was prodluced only
wlhen pareintal tlhymocytes were inoculated andI then only wlhen BMIDC were
adclecl. Botlh the parental (P<0.01) and the syngenieic (P<0.005) B'MDC were
ab)le to procluce the splenomegaly in cooperation witlh tlle parental tllymocytes.
As had been previously noted, the pareintal thymocytes wlhen inoculated alone,
pro(luced spleenis that were significanitly smaller tlhan those of uniinoctulate(d coIn-
trols (P<(.005)(7).
Sinice isologoLus B\IDC syn-iergized as well as pareiital BMIDC witli parental
tliymocytes, we p)erformedl several experiments to see whetlher otlher types of
syi-geneic lymplhoid tissue could also syngergize with parental thymocytes.
First isologous spleens were compare(d witlh parental BMIDC. The spleen cell
l)opulation cointains T cells andI tlherefore this experimenit tests wlhether or not
the presenice of syngenieic T cells affects the synergy. The results (Table 2) slhow
thlat the isologous spleen cells were able to synergize (P<0.001) as well or perhaps
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even better than were the parental BMDC (P<0.001). (All recipient mice received
a total of 4 x 107 cells; cell combinations were in a 1:1 ratio.) As previously
noted, giving tlhymocytes without BMDC or spleen cells resulted in the produc-
tion of significantly smaller spleens (P<0.001).
In the next experiment a comparison was made between the capacity of spleen
cells from adult (7 week old) and newborn spleen cells to synergize with parental
tlhymocytes. Adult spleen cells contain a much hiiglher proportion of immunologi-
cally competent cells and therefore should the isologous population require im-
munologic competence to enact synergy, the adult cell population shoul(d
synergize better. All mice (except the radiation controls) received a total of 3 X
107 cells in this experiment (again cell combinations were in a 1:1 ratio). Tlle
results (Table 3) slhow that both adult (P<0.005) and newborn (P<0.005) spleen
cells synergized witlh parental thymocytes equally well. As noted before, parental
tlhymocytes given alone prodluced significantly smaller spleens (P<0.001).
In the next experiment a comparison was made between syngeneic lymph node
cells and syngeneic bone marrow cells in their ability to synergize witlh tlle
parental thymocytes in the production of splenomegaly. This experiment dliffere(d
TABLE 1
INTERACTION OF DIFFERENT THYMOCYTE AND BMDC POPULATIONS IN GCVH REACTIONS:
REQUIREMENT FOR FOREIGNNESS OF CELLS
Origin of cells
inoculated Number of Spleen in(lexa X 10-`
Thymocytes BMDC mice (± SID)
C3H 0 5 289 ±4)58
C3H C3H 8 563 ± 77
C3H CDF, 8 508 ± 88
CDF1 0 5 403 ± 4 39
CDF1 C31-1 11 382 ± 47
CDF, CDF, 7 429 ± 49
0 0 10 395 51
0 C3H 5 417± 75
0 CDF, 5 344 ± 28
a Spleen/bo(ly weight ratio on (lay 14. All recipient CDF, imice got 350 R.
'TABLE 2
COMPARISON OF PARENTAL, BMDC WITH ISOLOGOUS SPLEEN CEILIS IN THE ABILITY TO
INTERACT WITH PARENTAL TiiYMOCYTES IN GX'H REACTIONS
Cells i;loctIlate(I Ntumber of SpleenI IIn(dexa X 10-}
Thymocytes Other Imlice (± SD)
C3H 0 6 196±-35
C3H C3H BMDC (6 596 ± 80
C3H CDF, Spleen (6 733 ± 1C4)6
0 0 6 449 ± 51
0 C3H BMDC 6 367 ± 16
0 CDF, Splecen 6 336 ± 17
a Spleen/body weight ratio on day 14. All recipient CDF, mice got 350 R.
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somewhat from the previous experiments in that instead of controlling for the
total cell inoculum as had previously been done, we controlled for the numbers
of each cell population. Thus, animals getting two different cell populations
received a total of twice as many cells (3 X 107) as animals getting a single type
of cell (1.5 x 107). The results (Table 4) differ from those previously noted. In
this instance, thymocytes alone produced significant splenomegaly (P<0.001). In-
deed animals getting only parental thymocytes had the largest spleens. Combining
the parental tlhymocytes with isologous bone marrow also resulted in splenomega-
ly when compared to animals which got either no cells (P<0.01) or bone marrow
cells (P<0.005) alone. However, the animals getting parental thymocytes and
isologous lymph node cells had spleens that were no larger than the animals
that got the lymph node cells alone. Thus, in this experiment the lymplh node
cells had an antagonistic effect on the splenomegaly produced by the parental
tlhymocytes. The fact that thymocytes alone in this instance produced splenomega-
ly complicated the interpretation of these results. However, it is clear that the
addition of lymph node cells which contain a much greater number of im-
munologically competent cells than do bone marrow cells did not increase the
splenomegaly. Indeed the opposite was true; the lymph node cells decreased the
splenomegaly produced by parental thymocytes (P<0.025) more than the bone
marrow cells (P = N.S.). The significance of this is taken up in the discussion.
TABLE 3
COMPARISON OF NEWBORN WITiH ADULT ISOLOGOUS SPLFFN CELLS IN THE ABILITY TO
INTERACT WITH PARENTAL THYMOCYTES IN GVH REACTIONS
Cells inoculated Number of Spleen Indexa X 10-5
Thymocytes Spleen mice (± SD)
C3H 0 5 300 ± 13
C3H Adtult 7 644 ± 161
C3H Neewborn 7 657 ± 103
0 0 5 411 22
0 Adult 5 372 ± 34
0 Newvborn 5 439 ± 56
"Spleen/body weight ratio on day 14. All recipient CDF, mice got 350 R.
TABLE 4
COMPARISON OF ISOLOGOUS LYMPH NODE WITH ISOLOGOUS LONE MARROW CELLS
IN THE ABILITY TO INTERACT WITH PARENTAL THYMOCYTFS IN GVH REACTIONS
Cells inocuilated Number of Spleen Indexa X l0-a
Thymocytes Other mice (± SD)
C3H 0 7 585 ± 132
C3H Lymph node 5 397 ± 33
C3H Bone marrow 7 489 ± 111
0 0 5 325±19
0 Lymph node 8 394 ± 57
0 Bone marrow 8 332 ± 19
* Spleen/body weight ratio on day 14. All recipient CDF1 mice got 350 R.
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These experiments indicate that the presence of increased numbers of syn-
geneic immunologically competent lymphocytes, either T or B, does not increase
the splenomegaly resultant from their interaction with foreign thymocytes. In
the following experiment we tried to demonstrate some immunologic role for
the syngeneic cells by another means.
We reasoned that if the increased spleen weight reflected a generation of im-
munologically competent cells, then these cells might be able to produce GVH
splenomegaly on their own upon transfer to another recipient. Thus, we gave
two groups of CDF, mice 350 R of X-irradiation. One group was then inoculated
with 1.5 X 107 parental thymocytes and the other group received the same num-
ber of parental tlhymocytes plus 1.5 x 107 isologous spleen cells. Two weeks later,
the spleens were harvested and weighed; spleen cell suspensions were then made
and reinoculated into other sublethally irradiated F1 recipients. Three different
concentrations of spleen cells were given to eight mice each. There were: 1.5 X
107 cells, a 1:3 dilution of that and a further 1:3 dilution. These secondary re-
cipients were killed 2 weeks later and their spleen body weight ratios were
determined.
There was no significant difference in results between the groups getting the
tlhree concentrations and tlherefore the pooled data are presented in Fig. 1. It
can be seen that, similar to the last reported experiment and in contrast to the
earlier experiments, primary recipients which received parental thymocytes alone
had more splenomegaly than those that got the thymocytes plus isologous spleen
cells (P<0.025). Secondary transfers of equivalent numbers of cells from both
groups of mice however, produced similar splenomegaly on retransfer. The
amount of splenomegaly was quite small, but statistically significant (P<.001).
If there was any difference at all between the two groups it was that the cells
from the mice with smaller spleens produced more splenomegaly on secondary
transfer. Tlhus this experiment failed to reveal any increased immunologic com-
petence as the result of the increased cell proliferation in spleens of mice under-
going a GVH reaction.
We, therefore, made a different attempt to see if we could demonstrate any
immunologic competence in BMIDC in the production of GVH. To do this, we
took 26 C3H mice and (leprivedI them of T cells by thymectomy, lethal irradlia-
tion and bone marrow grafting. Half of these were reconstituted with 3 X 107
syngeneic thymocytes. All mice were then given a DBA skin graft and observed
for 2 months. The tlhymocyte-reconstituted mice all rejected their skin grafts
with a mean rejection time of 16.3 days. Eight of 13 mice from the unreconsti-
tuted group rejected their skin grafts with a mean rejection time of 37.3 days.
At this time, all the mice were killed and spleen cell suspensions were made. Some
of these cells, from both groups of mice, were then treated with an anti-theta
serum and guinea pig complement. Controls were incubated with complement
alone. After treatment the cells were inoculated into CDF1 mice that had received
350 R of X-irradiation. Two weeks later the recipients were killed and spleen/
lbody weight ratios determined (Fig. 2).
The results slhow that spleen cells from both groups of animals were able to
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produce significant splenomegaly. The splenomegaly was not significantly greater
with the spleen cells from animals which had been reconstituted with thymo-
cytes. However, in both groups of animals the splenomegaly was significantly
reduced by treating the spleen cells with the anti-theta anti-serum. Thus, al-
thouglh cells from putatively thymus-deprived mice could produce GVH sple-
nomegaly after they were immunized to the antigens in the F1 host, at least a
significant portion of tlhem contained the theta antigen, and therefore were most
likely T cells wlhich had not been eliminated by our thymus-deprivation(27).
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DISCUSSION
The experiments reported were designed primarily to test the possibility that
some form of cell-mediated autoimmune potential was conveyed to syngeneic
(F,) cells when they were induced to proliferate by parental thymocytes in GVH
situations. In the course of these studies we confirmed previous reports that
tliymocytes and BMDC can synergize in the production of GVH splenomega-
ly(7,8). In addition we noted a new finding wherein parental thymocytes and F1
cells, either spleen (Fig. 1) or LN (Table 4), acted "antergistically." ("Antergy" is
a more proper antonym for synergy than is antagonism, and avoids the implica-
tion that one cell acts in opposition to the other; a more complex series of inter-
actions is possible.) This new findling has been analyzed in detail in a separate
communication(28) and our primary concern here is with its effect on the inter-
pretation of the data. The question we lhave asked is "does the interaction be-
tween parental and lhost (F1) cells, whiclh occurs in GVH reactions, confer any
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reconstituted with 3 X 107 thymocytes. Half of each group of (lonor cells were treated with
anti-theta plus complement anid half wvith complement alone. Each recipienit got 2 X 107 (pCe-
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autoimmune potential on the host cells?" Since the interactions we reported
wero synergistic in three experiments and antergistic in two others can we com-
pare interexperiment results? We can if we assume that the increased splenomega-
ly in any given experiment is dlue to increased proliferation of host (Fl) cells,
either of endogenous or exogenous origin. A number of workers have established
that this is the usual case(14-19). We have shown that, under certain conditions
the parental thymocytes cooperate with endogenous host (F1) cells which remain
after 350 R ancl the addition of more host (F1) cells may prevent the coopera-
tion(28). In these situations then, we think that comparisons of the immune
potential of spleen cells whichi have proliferated excessively (i.e., given greater
splenomegaly) can be ma(le with those that have proliferatecl less, as the increased
proliferation is a measurement of the response of the host (F1) cells.
We founcl thiat excess proliferation of host cells was not associated with an
increased capacity of the spleen cells to mount an immunologic attack on F1
hosts. We also founcl that tlheta + cells were primarily responsible for the in-
creased GVH activity dlisplaye(l by spleen cells of both thymus-deprive(d and
thymus-cleprive(d thymocyte-reconstituted parental mice whiclh had been grafted
with skin of the reciprocal parent in the F1 cross. In conjunction, these results
suggest that in cellular immuniity, in contrast to IlLmoral, most B cells or BMIDC
(lo not acquir-e immune potential in the presence of T cells or that if they do,
this results in their becominig theta +.
In aclclition, we showed that synergistic reactioins between parental thymocytes
aindl Fl cells (lidl not dlepen(d on the presence of T cells in the F1 poptilations.
This also suggests that the incr-eased splenomegaly resultiing from interactions
between parental andl F, cells (loes not (lepen(l on the acquisitioIn of any immulle
potential in the F1 populationi.
McNeill lhas slhowin that ,intigenic stimtlation results in the prodluction of
factor(s) whiclh stimulate lhematopoietic stem cells(29-31). The release of suchI
factoris (lutring GVH reactionis couldl accotuint for the proliferative reactions of
tl1e host cells that we andl otlhers(14-l9) have (lescribed. Elkins has recently put
forlth a perstuasive argulmenit that stuch is the case(32) andl tlle results we have
presented, by fatiling to find( an immuntologic componient in the proliferative
reactioni, lendl inclirect stuport to that view.
Stuperficially, it would appear that the basis for the synergistic reactionls we
lhave reported, as well as those noted by Hilgard(8), is different from tllat for
the reactions note(d by Asofsky, Cantor ancd Tigelaar(33). The synergy in tlle pro-
dIuction of GVH splenomegaly noted by those authors require that both inter-
acting cells be 7 cells and also that they both be parental. Their assay is per-
formed in newborn mice however, whiclh might be expected to have sufficient
endogenous cells for the parental cells to cooperate with. Our sublethally ir-
radiated mice lack such cells and that is probably wlhy we get synergistic reactions.
Nonetheless, one must keep open the possibility that the activation of nonim-
Inunologic F1 cells by parental T cells is a manifestation or reflection of mecha-
nisms in whiclh they are activating each other.
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SUMMARY
The nature of the interaction between parental thymus cells and various host
cell populations in the production of graft versus host (GVH) splenomegaly in
stublethally irradiated F1 recipients was investigated. Both synergistic and an-
tagonistic (antergistic) reactions occurred. All F1 populations investigated (lymph
nodes, bone marrow, bone marrow derived spleen, adult spleen and newborn
spleen cells) affected the GVH splenomegaly produced by the parental thymo-
cytes. The immunologic consequences of these interactions were investigated.
Retransfer of spleen cells of F1 mice undergoing GVH reactions gave no evi-
dence that the parental:F1 interactions which resulted in increased splenomegaly
yieldedl any increased anti-F1 immune potential of the cells in the spleen. Spleen
cells of thiymus-deprive(d C3H mice which had rejected a DBA skin graft had
increased GVH potential in CDF1 (C3H x DBA) recipients, but this was medi-
ated by theta-positive cells, most likely residual T cells. Thus, we suggest that
parental:host cell interactions in GVH (lisease do not convey significant cell
mediated autoimmune potential to the host cells and that the proliferation of
bone marrow-derived cells as a result of the attack mounted by parental thymo-
cytes is immunologically nonspecific.
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